Robeco Institutional Asset Management B.V. Grows Holdings in Align Technology, Inc. $ALGN

Key Points

• Robeco Institutional Asset Management B.V. increased its stake in Align Technology, Inc. by 286.2% during the second quarter, bringing their total to 144,189 shares valued at approximately $27.3 million.
• Align Technology's CEO, Joseph M. Hogan, purchased 7,576 shares at around $131.49 per share, raising his total ownership to 184,945 shares worth over $24 million.
• Align Technology has announced a $200 million stock buyback program, indicating confidence that its shares are undervalued, alongside recent analyst ratings with an average target price of $215.00.

Robeco Institutional Asset Management B.V. boosted its holdings in Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 286.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 144,189 shares of the medical equipment provider's stock after purchasing an additional 106,853 shares during the quarter. Robeco Institutional Asset Management B.V. owned about 0.20% of Align Technology worth $27,299,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Compagnie Lombard Odier SCmA acquired a new position in shares of Align Technology during the first quarter worth about $32,000. Center for Financial Planning Inc. acquired a new position in shares of Align Technology during the first quarter worth about $35,000. SVB Wealth LLC acquired a new position in shares of Align Technology during the first quarter worth about $36,000. Farther Finance Advisors LLC increased its stake in shares of Align Technology by 42.2% during the second quarter. Farther Finance Advisors LLC now owns 310 shares of the medical equipment provider's stock worth $59,000 after acquiring an additional 92 shares during the period. Finally, Mather Group LLC. increased its stake in shares of Align Technology by 375.0% during the first quarter. Mather Group LLC. now owns 437 shares of the medical equipment provider's stock worth $69,000 after acquiring an additional 345 shares during the period. Hedge funds and other institutional investors own 88.43% of the company's stock.

Insiders Place Their Bets

In other Align Technology news, CEO Joseph M. Hogan bought 7,576 shares of the company's stock in a transaction on Friday, August 1st. The stock was purchased at an average cost of $131.49 per share, for a total transaction of $996,168.24. Following the acquisition, the chief executive officer owned 184,945 shares of the company's stock, valued at $24,318,418.05. The trade was a 4.27% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 0.66% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on the stock. Mizuho set a $210.00 price target on shares of Align Technology in a research note on Thursday, July 31st. Morgan Stanley reiterated an "equal weight" rating and issued a $154.00 price target (down previously from $249.00) on shares of Align Technology in a report on Thursday, July 31st. Stifel Nicolaus cut their price target on shares of Align Technology from $275.00 to $200.00 and set a "buy" rating for the company in a report on Thursday, July 31st. Evercore ISI increased their price target on shares of Align Technology from $200.00 to $220.00 and gave the company an "outperform" rating in a report on Wednesday, July 9th. Finally, Wells Fargo & Company cut their price target on shares of Align Technology from $246.00 to $199.00 and set an "overweight" rating for the company in a report on Thursday, July 31st. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $215.00.

Align Technology Trading Up 2.7%

NASDAQ:ALGN opened at $132.17 on Friday. The firm has a 50-day moving average price of $140.20 and a two-hundred day moving average price of $165.72. Align Technology, Inc. has a twelve month low of $122.00 and a twelve month high of $246.19. The company has a market capitalization of $9.58 billion, a P/E ratio of 22.29, a price-to-earnings-growth ratio of 1.45 and a beta of 1.70.

Align Technology (NASDAQ:ALGN - Get Free Report) last posted its earnings results on Wednesday, July 30th. The medical equipment provider reported $2.49 earnings per share for the quarter, missing the consensus estimate of $2.57 by ($0.08). Align Technology had a net margin of 11.04% and a return on equity of 13.36%. The business had revenue of $1.01 billion for the quarter, compared to analysts' expectations of $1.06 billion. During the same quarter last year, the business posted $2.41 earnings per share. The business's revenue was down 1.6% compared to the same quarter last year. Align Technology has set its Q3 2025 guidance at EPS. On average, equities research analysts predict that Align Technology, Inc. will post 7.98 earnings per share for the current year.

Align Technology announced that its board has initiated a stock buyback program on Tuesday, August 5th that permits the company to buyback $200.00 million in outstanding shares. This buyback authorization permits the medical equipment provider to purchase up to 2% of its shares through open market purchases. Shares buyback programs are often a sign that the company's board of directors believes its shares are undervalued.

Align Technology Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.

Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.